> ## Content Index
> Fetch the complete content index at: https://www.pennystocks.news/llms.txt
> Use this file to discover other available public pages before exploring further.

# INVO Fertility's share count has roughly quintupled since December while its Q2 profit rests on a one-time gain
- URL: https://www.pennystocks.news/ivf-invo-fertility-s-share-count-has-roughly-quintupled-sinc/
- Published: 2026-08-17T23:42:35.000Z
- Updated: 2026-08-25T01:39:10.000Z
- Description: INVO Fertility, which operates fertility clinics and makes an intravaginal culture device, closed 57% higher on August 17 after releasing second-quarter 2026 results — results that showed a swing to net profit driven almost entirely by a one-time accounting gain, not by
- Author: PennyStocksNews Team
- Tags: nasdaq, ticker-ivf

INVO Fertility, which operates fertility clinics and makes an intravaginal culture device, **closed 57% higher on August 17 after releasing second-quarter 2026 results** — results that showed a swing to net profit driven almost entirely by a one-time accounting gain, not by operating improvement.

INVO Fertility, Inc. NASDAQ: IVF 

Shares closed at $1.53, up from a previous close of $0.9716\. Dollar volume was $277,057,422 across 745,853 trades. The free float was 1,778,532 shares; short volume on the session was 20,615,242 shares, equal to 56.08% of reported volume.

The company said in an August 17 press release via GlobeNewswire that **second-quarter revenue was $2,175,485, up 17% year over year**. Net income for the quarter came to approximately $0.9 million, compared with a net loss of approximately $3.6 million in the second quarter of 2025.

The quarterly profit depended on a non-operating item. The company recognised an **approximate $2.5 million gain on remeasurement related to the Birmingham clinic acquisition**, which it completed in June 2026 — a one-time item, not recurring operating income. Separately, the loss from operations was **approximately $1.3 million for the quarter**, narrower than the year-earlier period but still a loss, the press release said.

A structural change visible in the 10-Q filed with the SEC on August 14 is the scale of share issuance over the first half of 2026\. **Common shares outstanding stood at 477,366 at December 31, 2025**, and **had risen to 2,295,035 by June 30**, roughly five times the year-end count. By the filing date of August 14, the count had increased further to 2,506,969\. The 10-Q shows the expansion came through a combination of preferred stock conversions, warrant exercises, and other equity issuances. Each such transaction reduces the fraction of the company that existing common holders own.

The 10-Q balance sheet showed **cash of $3,732,945 at June 30, 2026**, against $2,077,842 at December 31, 2025.